Universe Pharmaceuticals INC (UPC)

NASDAQ: UPC · Real-Time Price · USD

3.240

-0.010 (-0.31%)

At close: Jun 12, 2026, 4:00 PM EDT

3.240

0.00 (0.00%)

After-hours: Jun 12, 2026, 6:50 PM EDT

UPC Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	17,859	23,025	32,309	40.14	47.98
Revenue Growth (YoY)	-22.44%	-28.74%	80383.62%	-16.34%	56.27%
Cost of Revenue	11,558	16,953	21,994	18.25	22.66
Gross Profit	6,301	6,072	10,315	21.89	25.33
Selling, General & Admin	8,545	11,061	9,423	21.27	6.27
Research & Development	671.76	3,031	4,859	7.64	5.47
Total Operating Expenses	9,217	14,092	14,281	28.91	11.74
Operating Income	-2,916	-8,020	-3,966	-7.02	13.59
Interest Income	65.06	31.94	31.07	0.04	0.27
Interest Expense	-232.04	-278.17	-156.79	-0.16	-0.1
Other Non-Operating Income (Expense)	-589.15	145.48	-235.61	0.05	-0.08
Total Non-Operating Income (Expense)	-756.14	-100.75	-361.33	-0.07	0.09
Pretax Income	-3,672	-8,121	-4,327	-7.09	13.68
Provision for Income Taxes	-	-606.7	-2,254	-0.82	-2.36
Net Income	-3,672	-7,514	-2,074	-6.28	16.04
Net Income to Common	-3,672	-8,727	-6,581	-7.91	11.32
Net Income Growth	-	-	-	-	49.77%
Shares Outstanding (Basic)	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0
Shares Change (YoY)	3174.93%	130.39%	-	14.59%	18.63%
EPS (Basic)	-8.06	-626.96	-1089.21	-1309.11	2147.99
EPS (Diluted)	-8.06	-626.96	-1089.21	-1309.11	2147.99
EPS Growth	-	-	-	-	26.95%
Free Cash Flow	-5,319	-9,752	1,073	-1.39	-15.59
Free Cash Flow Per Share	-11668.00	-700609.00	177525.00	-230.84	-2956.31
Gross Margin	35.28%	26.37%	31.93%	54.53%	52.78%
Operating Margin	-16.33%	-34.83%	-12.28%	-17.49%	28.32%
Profit Margin	-20.56%	-32.63%	-6.42%	-15.64%	33.42%
FCF Margin	-29.78%	-42.36%	3.32%	-3.47%	-32.49%
EBITDA	-2,398	-7,534	-3,457	-6.49	14.04
EBITDA Margin	-13.43%	-32.72%	-10.70%	-16.16%	29.25%
EBIT	-2,916	-8,020	-3,966	-7.02	13.59
EBIT Margin	-16.33%	-34.83%	-12.28%	-17.49%	28.32%
Effective Tax Rate	0.00%	7.47%	52.08%	11.49%	-17.24%

SEC Filings: 10-K · 10-Q